BEYAZ ALERT

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Lawsuits Are Being Filed Against Bayer, the Makers of Beyaz, Claiming Serious Complications

According to class action lawsuits filed nationwide, Beyaz has caused women to have serious side effects including gallbladder disease, stroke, blood clots and death.

If you or a family member have or currently use Beyaz and have been injured, you may be entitled to compensation.

Bayer paid $1.4 billion to settle close to 7,000 blood clot lawsuits

Bayer has created a fund of $24 million for gallbladder claims for more than 8,000 plaintiffs

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

BEYAZ ALERT

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in medical device lawsuits.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit.

About Beyaz

Beyaz is an oral contraceptive which is prescribed to avoid pregnancy. It is the “sister” medication to Yaz and Yasmin. All are manufactured by Bayer Pharmaceuticals.

All oral contraceptives contain ethinyl estradiol, a man-made estrogen-like hormone that increases clotting factors in the blood. Some studies show that the newer contraceptives with third and fourth generation progestins have a different reaction with ethinyl estradiol and carries a greater risk than older medications. Beyaz contains drospirenone, a fourth generation progestin.

Beyaz and other oral contraceptives containing drospireone have caused women serious side effects such as gallbladder disease, stroke, blood clots and death. Many women who have suffered from these adverse effects have filed class action lawsuits claiming they were not adequately warned of the dangers of taking Beyaz and Bayer knew or should have known about these dangerous side effects.

TRIBENZOR ALERT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Tribenzor May Lead to Kidney Failure and Cause Serious Gastrointestinal Problems

Studies show Tribenzor, used to treat high blood pressure, may lead to kidney failure and/or sprue-like enteropathy including severe diarrhea, weight loss and malnutrition.

If you or a family member has used Tribenzor and have been injured, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

TRIBENZOR ALERT

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in lawsuits involving defective drugs.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its

About Tribenzor

Tribenzor, made by Daiichi Sankyo, Inc., was approved by the FDA in 2010 to treat high blood pressure. The drug is an angiotensin II receptor blocker that lowers blood pressure by relaxing the blood vessels and eliminating some of the salt and water in the bloodstream. Studies show that, Tribenzor, which contains olmesartan, can cause sprue-like enteropathy which causes severe diarrhea and severe weight loss. Tribenzor can also cause muscle damage that can lead to kidney failure. In 2013, the FDA issued a warning that Tribenzor, and other drugs that contain olmesartan, may increase the risk of sprue-like enteropathy.

DEFECTIVE BRAKE SYSTEMS ON 2006-2010 HYUNDAI SONATAS ALERT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Class Action Lawsuit Filed Against Hyundai Alleging Hyundai Knowingly Sold Defective Brake Systems

According to the class action complaint filed June 17, 2015, Hyundai manufactured and sold defective brake systems in Hyundai Sonatas for model years 2006-2010. These defective brake systems can cause premature deterioration and failure when the brakes are applied. This presents an excessive danger to the consumer and the driving public.

If you or a family member currently owns a Hyundai Sonata model year 2006-20010 and have experienced early brake deterioration or failure, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

DEFECTIVE BRAKE SYSTEMS ON 2006-2010 HYUNDAI SONATAS ALERT

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in defective products lawsuits.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit [consider linking “CONTACT US NOW” again to our number and/or the “CLAIM FORM”].

About Defective Brake Systems on 2006-2010 Hyundai Sonatas

A class action complaint was filed on June 17, 2015 in the United States District Court for the District of New Jersey alleging Hyundai designed, manufactured, tested, marketed, distributed and knowingly sold defective braking systems on the 2006-2010 Hyundai Sonatas. According to the plaintiffs, these defective braking systems cause significant squeaking and unreasonably premature break down of the rotors and pads. If the condition is not rectified by replacing the entire braking system, complete braking failure can occur. This presents an extreme danger to not only the driver, but also the driving public. The complaint further alleges Hyundai knew of the defect and its effects through previously released data, testing, maintenance reports and customer complaints. Finally, plaintiffs accuse Hyundai of concealing and failing to disclose this information to the consumer at the time of vehicle purchase. To date, Hyundai has not recalled or offered to repair or replace the defective braking system, leaving the costs of the repairs and/or replacement to the consumer.

HOOSIER RACING TIRES ALERT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Class Action Lawsuit Filed Against Hoosier Racing Tire Corporation Failed to Disclose a Major Defect in its Hoosier D.O.T. – Radial Racing Tires

A class action lawsuit was filed on June 18, 2015 alleging the Hoosier Racing Tire Corporation knowingly sold defective tires causing blowouts and leaving drivers unable to control their cars.

If you or a family member have or have had Hoosier D.O.T. Radial Racing Tires and have experienced a blowout on any of the tires and have been injured, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

HOOSIER RACING TIRES ALERT

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in defective products lawsuits.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit.

About Hoosier D.O.T. Radial Racing Tires

A class action lawsuit was filed on June 18, 2015 in the United States District Court for the Middle District of Florida alleging Hoosier Racing Tire Corporation manufactured and sold defective racing tires. The complaint asserts that the tires tend to have tread separation which leads to a “wart like” growth in the middle of the tire. This results in a large amount of vibration and eventual tire blow out leaving the driver with virtually no control of the car. This tire defect can result in damage to the race car, damage to the racetrack facility and replacement of the tires which are valued at $1200-$1400 per set.

Plaintiff further alleges that Hoosier Racing Tire Corporation knew or should have known of the tire defect and failed to warn the public of said defect. To date, the company has not recalled the racing tires nor offered to reimburse its customers for any expenses due to the repair or replacement of the defective tires.

DEFECTIVE GENERAL ELECTRIC GAS RANGE OVENS ALERT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Class Action Lawsuit Filed Against General Electric Alleging GE Knowingly Manufactured and Sold Defective Gas Ranges

According to the class action complaint filed June 17, 2015, GE manufactured and sold the defective 40” Free Standing Gas Range oven (Model JGB600EEDES) causing the surface knob to be turned and flammable gas to be released when the oven is subject to minor bumps. It also contains an ignition system defect which does not ignite gas in a timely manner.

If you or a family member currently or has owned the GE 40” Free Stranding Gas Range (Model JGB600EEDES) and have been injured or have had to repair or replace said oven, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

DEFECTIVE GENERAL ELECTRIC GAS RANGE OVENS ALERT

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in defective products lawsuits.
No Charge or Obligation for Our Experienced Attorney Review

About GE Defective Gas Range Ovens

A class action complaint was filed on June 17, 2015 in the United States District Court for the District of New Jersey alleging General Electric designed, manufactured, tested, marketed, distributed and knowingly sold defective gas range ovens. The 40” Free Standing Gas Range oven, model JGB600EEDES all contain the same surface knob and ignition system defects. The complaint states when the knobs are subject to minor, everyday bumps or movement, the burner valve opens and releases flammable gas. This release of gas creates an unreasonable and often dangerous risk for the consumer. The complaint continues to state the ovens also contain an ignition system defect which causes a delay igniting the released gas. According to the complaint, GE has not offered to repair or replace the defective gas ovens, leaving the consumer with a defective product which needs to be repaired or replaced at their expense.

FOSTER POULTRY FARMS INC.’S LAWSUIT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES – WE ARE AVAILABLE TO ASSIST YOU IN SEEKING RECOVERY

Class Action Lawsuit Filed Against Foster Farms Alleging the American Humane Association Certification Label is Misleading

According to a complaint filed on July 13, 2015, despite labeling their products with a certification from the American Humane Association, Foster Farms chickens are mutilated and mistreated before enduring painful deaths.

If you or a family member have purchased Foster Poultry Farms chicken and did so believing the chicken was produced in humane conditions, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

FOSTER POULTRY FARMS INC.’S LAWSUIT

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in consumer lawsuits.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merits.

About The Class Action Lawsuit Against Foster Farms

A Class Action complaint was filed against Foster Poultry Farms Inc. on July 13, 2015 in the Superior Court of the State of California for the County of Los Angeles alleging the defendants engaged in false and misleading advertising when it labeled its chicken with a certification from the American Humane Association (“AHA”). The complaint states the certification label creates a reasonable expectation to the consumer that the chicken they are purchasing was produced in humane conditions. The plaintiff states she discovered the AHA certification doesn’t require special treatment of chickens. According to the complaint, the AHA standards just require the eggs to come from facilities that avoid contagion. The plaintiff describes a number of abuses the chickens allegedly suffer at Foster Farms including forced molting and beak-trimming; being starved and not given water; and male chicks being ground up alive. Plaintiff contends that she relied on the AHA certification label when making her purchase and believed the chicken she purchased was created in humane conditions.

ESSURE IMPLANT ALERT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Lawsuits Are Being Filed Against Bayer, the Makers of Essure Implants, Claiming Serious Complications

According to class action lawsuits filed nationwide, Essure has caused women painful menstrual periods, perforated fallopian tubes, and migration of the device to other nearby organs

If you or a family member has or have had Essure implants and have been injured, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

ESSURE IMPLANT ALERT

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in medical device lawsuits.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit.

About Essure Implants

Essure is a permanent contraceptive implant device. The device is a small metal polyester coil which is placed in a woman’s fallopian tubes causing complete and permanent sterilization without a surgical procedure. It works but creating inflammation in the tubes creating scar tissue which blocks the fallopian tubes passage ways. Essure was originally manufactured by Conceptus, which Bayer acquired in 2013.

The Essure implant was approved by the FDA in 2002. According to the FDA, there have been more than 4,000 events reported including severe back pain, painful and prolonged menstrual periods and pierced fallopian tubes which caused the device to be lodged in nearby organs.

Essure can cause serious complications including painful menstrual periods, vaginal bleeding, perforated fallopian tubes, device expulsion, device migration and extreme pain during intercourse. Women who have suffered adverse effects through the use of Essure have filed class action lawsuits claiming the device is defective and caused them injury. Plaintiffs also allege that Bayer took part in misleading marketing and failed to warn the public of the potential dangerous side effects of Essure. In fact, in April 2015 the FDA opened an investigation amid allegations Bayer falsified and changed the medical records during clinical trials, failed to report negative results, deceived the public and the FDA about device safety and efficiency; and used defective materials during the manufacturing process.

DILANTIN ALERT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Dilantin Can Cause Stevens Johnson Syndrome and Toxic Necrolysis Syndrome, Potentially Deadly Skin Diseases

According to class action lawsuits filed against Pfizer, the makers of Dilantin, the drugs have caused severe skin diseases caused by and allergic reaction.

If you or a family member has taken Dilantin and have been injured, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

DILANTIN ALERT

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in lawsuits involving defective drugs.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its

About Dilantin

Dilantin (generic: phenytoin) is a commonly prescribed medication used to treat epilepsy and seizures. Dilantin was approved by the FDA in 2001. Since then there have been numerous reports of severe side effects affecting the skin. A major side effect is Stevens Johnson Syndrome (SJS), a potentially deadly skin disease which produces burn-like rashes, open sores and skin peeling. SJS is deadly between 5%-15% of the time. The drug has also been linked to Toxic Necrolysis Syndrome (TENS) which is deadly in 40%-40% patients. The side effects to these severe skin diseases include:

Flu-like symptoms (fever, sore throat, cough)
Red or purple skin rash
Hives
Blisters on the skin or mucous membranes, especially in the mouth, nose and eyes
Facial swelling
Tongue swelling
Skin pain
Skin shedding

Those taking Dilantin may also face cellulitis, sepsis, eye problems which can lead to blindness, internal organ damage and permanent skin damage. These side effects can last a lifetime.

Plaintiffs in class action lawsuits claim Pfizer, and the generic drug makers Mylan Pharmaceuticals and Baxter Healthcare, were aware of the drugs dangers but failed to adequately warn the public about the increased risks of the severe skin diseases.

DEPAKOTE ALERT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Depakote, Taken While Pregnant, Increases the Risk of Severe Birth Defects

According to class action lawsuits filed against Abbott Laboratories, the makers of Depakote, risks of having a baby born with birth defects are increased for mothers who took the drug while pregnant.

If you or a family member has taken Depakote prior to 2010 while pregnant and have a baby born with birth defects, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

DEPAKOTE ALERT

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in lawsuits involving defective drugs.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its

About Depakote

Depakote is a popular anticonvulsant drug used to treat epilepsy, migraine headaches and bipolar mania. The drug was approved by the FDA in 1983 to treat certain seizure conditions in adults and children 10 years and older. The drug was later approved to prevent migraine headaches as well as a long-term treatment for severe manic episodes of bipolar disorder. Depakote is the brand name for the generic drugs divalproex sodium, valproate and valproic acid.

Birth defects allegedly caused by Depakote include heart defects, brain defects, spina bifida and other spinal defects and face or skull defects. There have been a number of studies showing mothers are at an increased risk of giving birth to babies born with birth defects than those mothers who did not Depakote while pregnant.

In 2006, the FDA added a black-box warning regarding potential birth defects. The warning came as the result of a study reporting incidents of birth defects in 20% of women who gave birth while taking Depakote. In 2009, the FDA specifically warned about potential neural tube defects, heart defects and craniofacial birth defects.

In a 2010 study published in the New England Journal of Medicine, European researchers reported an increased risk of six different birth defects when Depakote is taken during the first trimester. The risk for spina bifida, in particular, increased 12 times for mothers who were prescribed the drug. In 2011, the FDA warned about a potential link between Depakote and decreased cognitive functioning. Studies have shown that, compared with children of women who did not take the drug, children born to mothers who took Depakote during pregnancy tended to score lower on IQ and other cognitive tests.

Plaintiffs in class action lawsuits claim Abbott Laboratories failed to adequately warn the public about the increased risks of birth defects in pregnant women taking Depakote prior to 2010.

CYMBALTA ALERT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Lawsuits Are Being Filed Against Eli Lilly, the Makers of Cymbalta, Claiming Serious Antidepressant Withdrawal Symptoms

According to class action lawsuits filed nationwide, Cymbalta has caused serious withdrawal symptoms including severe nausea, vomiting, dizziness and vertigo, hot/cold flashes, mood swings, nightmares, brain “zaps”, paresthesia (tingling, tickling, prickling or burning sensation of the skin), shaking hands and visual disturbances.

If you or a family member have used Cymbalta and have experienced withdrawal symptoms, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

CYMBALTA ALERT

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in medical device lawsuits.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit.

About Cymbalta

Cymbalta (duloxetine) is a serotonin-norepinephrine reuptake inhibitor (SNRI) made by Eli Lilly and is prescribed to treat major depression and generalized anxiety disorder. It is also approved to treat diabetic nerve pain, fibromyalgia and musculoskeletal pain associated with osteoarthritis and chronic lower back pain.

Studies have shown that 50%-78% of Cymbalta users experience antidepressant withdrawal symptoms after stopping the drug. However, the label states that only 1%-2% of users experience withdrawal symptoms. The class action lawsuits claim Eli Lilly failed to warn the public that the severity of the withdrawal systems were so severe that it was given its own diagnosis: Cymbalta Discontinuation Syndrome.

In 2009, the FDA issued a report that stated the Cymbalta withdrawal symptoms can be severe and last weeks or even months. The FDA also stated the company’s sales representatives and marketing materials do not adequately warn of the withdrawal symptoms and they have not developed a safe protocol for safely stopping Cymbalta. Furthermore, a study funded and conducted by Eli Lilly states up to 41% of Cymbalta users have antidepressant withdrawal symptoms and of those, 46% were moderate and 17% were severe. But the company still states on the drug label that these withdrawal symptoms are rare and only occur in about 1% of the users.